Normalised Returns
Healthcare Research, Analytics & Technology · closest in market valueVIMTALABS−13.8%Nifty Pharma+25.7%
Full Comparison
NSE filings · last close| Company | Price | Mkt Cap | P/E | P/B | ROE | Margin | Rev YoY | PAT YoY | D/E | 1Y Rtn |
|---|---|---|---|---|---|---|---|---|---|---|
| SYNGENE | ₹378.7 | ₹15,258 Cr | 69.0× | 3.15× | 6.6% | 8.5% | −15.8% | −110.4% | 0.00× | −38.4% |
| INDGN | ₹608.95 | ₹14,645 Cr | 36.5× | 4.67× | 13.9% | 11.4% | +39.7% | −0.2% | 0.00× | +6.3% |
| SUVEN | ₹335 | ₹8,835 Cr | – | 14.94× | -78.8% | -3884.1% | +91.0% | −147.7% | 0.00× | +66.0% |
| VIMTALABS ● | ₹599.3 | ₹2,677 Cr | 33.6× | 5.86× | 18.5% | 19.0% | +11.8% | +11.4% | 0.01× | −13.8% |
| TAKE | ₹15.51 | ₹229 Cr | 17.9× | 7.40× | 42.1% | 20.0% | – | +216.8% | 0.00× | +41.6% |
Healthcare Research, Analytics & Technology: the companies closest in market value, of the 5 in that basic industry whose filings we hold, from each company's NSE filings and the last close. Quarterly figures are for Q1 FY27; ROE, margin for FY26; P/B and D/E on the latest balance sheet. Green and red mark the two ends of a column; valuation and leverage columns are left plain. Hover a heading for its definition.
Against Healthcare Research, Analytics & Technology5 companies
P/E44.4×
18.3×median 40.2× · 2 of 4, highest first69.7×
P/B7.95×
3.18×median 7.59× · 2 of 5, highest first16.4×
ROE17.9%
-59.6%median 12.8% · 2 of 5, highest first41.4%
Net margin18.3%
-3998.7%median 10.5% · 1 of 5, highest first18.3%
Revenue growth4.9%
-3.4%median 11.1% · 3 of 4, highest first30.4%
Profit growth48.5%
-68.2%median -32.2% · 1 of 4, highest first48.5%
Debt / equity0.03×
0.00×median 0.00× · 1 of 5, highest first0.03×
Dividend yield0.3%
0.3%median 0.3% · 2 of 3, highest first0.4%
1-year price change-20.2%
-40.5%median 6.5% · 4 of 5, highest first52.5%
Everyone in Healthcare Research, Analytics & Technology whose filings we hold: 5 companies, its basic industry within Healthcare. Figures as the screener works them out (the last four quarters' profit, the latest balance sheet, the last close), so ROE can differ a little from the Financials tab's latest-year figure. A place in the line is a fact about a number, not a view on the company.
VIMTALABS Rankings
Among 5 companies compared
Profitability
2
ROE 18.5%2nd highest of 52
Net margin 19.0%2nd highest of 5Growth
3
Revenue YoY +11.8%3rd highest of 42
Net profit YoY +11.4%2nd highest of 5Leverage
5
Debt / equity 0.01×Highest of 5Valuation
2
P/E 33.6×2nd lowest of 43
P/Book 5.86×3rd lowest of 5Price
4
1-year return −13.8%4th highest of 5Position 1 is the lowest NPA, multiple or leverage, and the highest return, growth or profitability figure. These are positions among the companies listed here, not a view on the stock.